Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
388,917,807
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
343,293,098
-
Shares change
-
+5,727,010
-
Total reported value, excl. options
-
$2,286,399,131
-
Value change
-
+$28,506,338
-
Put/Call ratio
-
65%
-
Number of buys
-
116
-
Number of sells
-
-55
-
Price
-
$6.66
Significant Holders of LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST) as of Q1 2025
215 filings reported holding LFST - LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share as of Q1 2025.
LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 343,293,098 shares
of 388,917,807 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include TPG GP A, LLC (160,711,618 shares), SUMMIT PARTNERS L P (41,932,358 shares), FMR LLC (34,847,254 shares), BlackRock, Inc. (12,183,688 shares), VANGUARD GROUP INC (11,221,237 shares), JENNISON ASSOCIATES LLC (8,255,236 shares), MILLENNIUM MANAGEMENT LLC (5,834,348 shares), BROWN ADVISORY INC (5,822,615 shares), WELLINGTON MANAGEMENT GROUP LLP (5,399,293 shares), and MORGAN STANLEY (5,233,045 shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.